UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs

Computer methods and programs in biomedicine, 2001-05, Vol.65 (2), p.141-151

2001

Volltextzugriff (PDF)

The ISoP Standards and Best Practices Committee

Clinical pharmacology and therapeutics, 2014-06, Vol.95 (6), p.581-582

2014

Volltextzugriff (PDF)

Modeling the Kinetics of Release of Octreotide from Long‐Acting Formulations Injected Intramuscularly in Rabbits

Journal of pharmaceutical sciences, 2000-09, Vol.89 (9), p.1123-1133

2000

Volltextzugriff (PDF)

Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR

Journal of controlled release, 1999-05, Vol.59 (2), p.197-205

1999

Volltextzugriff (PDF)

Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice

British journal of pharmacology, 2004-04, Vol.141 (7), p.1214-1222

2004

Volltextzugriff (PDF)

Non-linear mixed effects modeling : From methodology and software development to driving implementation in drug development science

Journal of pharmacokinetics and pharmacodynamics, 2005-04, Vol.32 (2), p.161-183

2005

Volltextzugriff (PDF)

Optimization of individual and population designs using Splus

Journal of pharmacokinetics and pharmacodynamics, 2003-12, Vol.30 (6), p.417-443

2003

Volltextzugriff (PDF)

Stochastic optimization algorithms of a Bayesian design criterion for Bayesian parameter estimation of nonlinear regression models: Application in pharmacokinetics

Mathematical biosciences, 1997-08, Vol.144 (1), p.45-70

1997

Volltextzugriff (PDF)

Effect of efflux inhibition on brain uptake of itraconazole in mice infected with Cryptococcus neoformans

Drug metabolism and disposition, 2003-03, Vol.31 (3), p.319-325

2003

Volltextzugriff (PDF)

Sparse-Sampling Optimal Designs in Pharmacokinetics and Toxicokinetics

Drug information journal, 1995, Vol.29 (3), p.997-1019

1995

Volltextzugriff (PDF)

The use of simulated annealing for finding optimal population designs

Computer methods and programs in biomedicine, 2002-07, Vol.69 (1), p.25-35

2002

Volltextzugriff (PDF)

Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2

Cancer chemotherapy and pharmacology, 2005, Vol.55 (1), p.61-71

2005

Volltextzugriff (PDF)

Hyperparameter Estimation Using Stochastic Approximation with Application to Population Pharmacokinetics

Biometrics, 1988-09, Vol.44 (3), p.673-683

1988

Volltextzugriff (PDF)

Influence of confounding factors on designs for dose-effect relationship estimates. Discussion

Statistics in medicine, 1995, Vol.14 (9-10), p.987-1008

1995

Volltextzugriff (PDF)

Inferring systemic exposure from a pharmacokinetic screen : model-free and model-based approaches. Discussion

Statistics in medicine, 1995, Vol.14 (9-10), p.955-970

1995

Volltextzugriff (PDF)

A mathematical model of the kinetics of 5-fluorouracil and its catabolites in freshly isolated rat hepatocytes

Biochemical pharmacology, 1984-09, Vol.33 (17), p.2727-2732

1984

Volltextzugriff (PDF)

Action COST B15 : Modelling during drug development October 1998 to July 2004

Basic & clinical pharmacology & toxicology, 2005-03, Vol.96 (3), p.149-150

BALANT, Luc

2005

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Aktive Filter

ThemaHumans

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(15)
Tagungsberichte
(2)

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs

The ISoP Standards and Best Practices Committee

Modeling the Kinetics of Release of Octreotide from Long‐Acting Formulations Injected Intramuscularly in Rabbits

Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR

Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice

Non-linear mixed effects modeling : From methodology and software development to driving implementation in drug development science

Optimization of individual and population designs using Splus

Stochastic optimization algorithms of a Bayesian design criterion for Bayesian parameter estimation of nonlinear regression models: Application in pharmacokinetics

Effect of efflux inhibition on brain uptake of itraconazole in mice infected with Cryptococcus neoformans

Sparse-Sampling Optimal Designs in Pharmacokinetics and Toxicokinetics

The use of simulated annealing for finding optimal population designs

Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2

Hyperparameter Estimation Using Stochastic Approximation with Application to Population Pharmacokinetics

Influence of confounding factors on designs for dose-effect relationship estimates. Discussion

Inferring systemic exposure from a pharmacokinetic screen : model-free and model-based approaches. Discussion

A mathematical model of the kinetics of 5-fluorouracil and its catabolites in freshly isolated rat hepatocytes

Action COST B15 : Modelling during drug development October 1998 to July 2004

Aktive Filter

Suchergebnisse filtern